Q1 Earnings Estimate for electroCore Issued By HC Wainwright

electroCore, Inc. (NASDAQ:ECOR) – Investment analysts at HC Wainwright lowered their Q1 2025 earnings per share (EPS) estimates for electroCore in a note issued to investors on Thursday, March 13th. HC Wainwright analyst S. Ramakanth now expects that the company will post earnings per share of ($0.59) for the quarter, down from their prior estimate of ($0.26). HC Wainwright currently has a “Buy” rating and a $25.00 target price on the stock. The consensus estimate for electroCore’s current full-year earnings is ($1.49) per share. HC Wainwright also issued estimates for electroCore’s Q2 2025 earnings at ($0.45) EPS, Q3 2025 earnings at ($0.36) EPS, Q4 2025 earnings at ($0.29) EPS, FY2025 earnings at ($1.70) EPS, FY2026 earnings at $0.45 EPS and FY2027 earnings at $1.33 EPS.

Separately, LADENBURG THALM/SH SH cut their price objective on electroCore from $28.00 to $26.00 and set a “buy” rating on the stock in a research note on Thursday.

electroCore Trading Down 10.4 %

Shares of ECOR stock opened at $8.56 on Monday. The business’s 50-day moving average price is $15.84 and its 200-day moving average price is $12.35. electroCore has a 12 month low of $5.32 and a 12 month high of $19.49. The firm has a market capitalization of $56.98 million, a price-to-earnings ratio of -4.68 and a beta of 0.24.

Hedge Funds Weigh In On electroCore

A number of hedge funds and other institutional investors have recently made changes to their positions in the stock. Jane Street Group LLC acquired a new position in shares of electroCore in the fourth quarter worth approximately $278,000. Marshall Wace LLP acquired a new position in shares of electroCore in the fourth quarter worth approximately $438,000. NewEdge Advisors LLC acquired a new position in shares of electroCore in the fourth quarter worth approximately $274,000. Renaissance Technologies LLC lifted its stake in shares of electroCore by 80.6% in the fourth quarter. Renaissance Technologies LLC now owns 131,786 shares of the company’s stock worth $2,136,000 after acquiring an additional 58,800 shares during the period. Finally, DnB Asset Management AS bought a new stake in electroCore in the fourth quarter worth approximately $180,000. 26.74% of the stock is owned by institutional investors and hedge funds.

About electroCore

electroCore, Inc, a commercial stage bioelectronic medicine and wellness company, provides non-invasive vagus nerve stimulation technology platform in the United States, the United Kingdom, and internationally. The company is developing gammaCore, a prescription only handheld device intended for regular or intermittent use for the acute treatment of pain associated with migraine and episodic cluster headache, as well as for the treatment of hemicrania continua and paroxysmal hemicrania.